Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095

被引：0
|
作者：
Ali Afshar-Oromieh
Uwe Haberkorn
Christian Zechmann
Thomas Armor
Walter Mier
Fabian Spohn
Nils Debus
Tim Holland-Letz
John Babich
Clemens Kratochwil
机构：
[1] Heidelberg University Hospital,Department of Nuclear Medicine
[2] German Cancer Research Center,Clinical Cooperation Unit Nuclear Medicine
[3] Progenics Pharmaceuticals,Department of Biostatistics
[4] Inc.,Division of Radiopharmaceutical Sciences, Department of Radiology
[5] German Cancer Research Center,Citigroup Biomedical Imaging Center
[6] Weill Cornell Medicine,Meyer Cancer Center
[7] Weill Cornell Medicine,undefined
[8] Weill Cornell Medicine,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
Prostate cancer; PSMA; Prostate-specific membrane antigen; Endoradiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：950 / 959
页数：9
相关论文
共 50 条
  • [31] Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Kambiz Rahbar
    Martin Bögeman
    Anna Yordanova
    Maria Eveslage
    Michael Schäfers
    Markus Essler
    Hojjat Ahmadzadehfar
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 243 - 246
  • [32] Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Rahbar, Kambiz
    Boegeman, Martin
    Yordanova, Anna
    Eveslage, Maria
    Schaefers, Michael
    Essler, Markus
    Ahmadzadehfar, Hojjat
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (02) : 243 - 246
  • [33] PSMA-targeted radioligand therapy in metastatic prostate cancer: Comprehensive analysis of recent evidence
    Ovcaricek, Petra Petranovic
    Garo, Maria Luisa
    Giovanella, Luca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 52 (04) : 1242 - 1245
  • [34] PSMA radioligand therapy rechallenging: expanding the therapeutic possibilities in metastatic castration resistant prostate cancer
    Volpe, Fabio
    Piscopo, Leandra
    Klain, Michele
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (13) : 4163 - 4164
  • [35] Synthesis of a PSMA-targeting ligand with an optimized linker for imaging and treatment of prostate cancer
    Murce, Erika
    Spaan, Evelien
    Seimbille, Yann
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S206 - S207
  • [36] Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors
    James Kelly
    Alejandro Amor-Coarasa
    Shashikanth Ponnala
    Anastasia Nikolopoulou
    Clarence Williams
    David Schlyer
    Yize Zhao
    Dohyun Kim
    John W. Babich
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1841 - 1851
  • [37] Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer
    Murce, Erika
    Beekman, Savanne
    Spaan, Evelien
    Handula, Maryana
    Stuurman, Debra
    de Ridder, Corrina
    Seimbille, Yann
    MOLECULES, 2023, 28 (10):
  • [38] Impact of Modulating Albumin Affinity on Tumor and Normal Tissue Kinetics of PSMA-Targeting Ligands for Radioligand Therapy
    Kelly, J. M.
    Amor-Coarasa, A.
    Ponnala, S.
    Nikolopoulou, A.
    Williams, C., Jr.
    Babich, J. W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S52 - S52
  • [39] Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors
    Kelly, James
    Amor-Coarasa, Alejandro
    Ponnala, Shashikanth
    Nikolopoulou, Anastasia
    Williams, Clarence, Jr.
    Schlyer, David
    Zhao, Yize
    Kim, Dohyun
    Babich, John W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (11) : 1841 - 1851
  • [40] 177Lu -PSMA-I&T PSMA radioligand therapy in metastatic castration - resistant prostate cancer: First clinical trial in Asia
    Bu, Ting
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S527 - S528
12345